http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103396328-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 |
| filingDate | 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103396328-B |
| titleOfInvention | Meclofenoxate hydrochloride compound and pharmaceutical composition thereof |
| abstract | A meclofenoxate hydrochloride compound is a crystal. Determined by X-ray powder diffraction, the meclofenoxate hydrochloride compound has characteristic peaks at 2theta +/- 0.2 degree of 6.1 degrees, 7.7 degrees, 9.3 degrees, 12.2 degrees, 14.3 degrees, 17.8 degrees, 18.9 degrees, 20.5 degrees, 22.2 degrees, 23.3 degrees, 24.5 degrees, 25.8 degrees and 27.0 degrees in the spectrum pattern. The invention also discloses a pharmaceutical composition of the meclofenoxate hydrochloride compound. The dosage forms of the pharmaceutical composition comprise dispersing tablets, capsules, freeze-dried powder injection, and aseptic powder for injection. The meclofenoxate hydrochloride compound has extremely good fluidity as well as stable quality. The benefits comprise that the dispersing tablets, the capsules and the freeze-dried powder injection of the prepared meclofenoxate hydrochloride compound has good stability and low impurity content. |
| priorityDate | 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.